Literature DB >> 10267273

Physician perceptions of medical malpractice and defensive medicine.

M S Thompson, C P King.   

Abstract

Using judgments obtained in interviews with 33 Massachusetts physicians, the annual statewide volume of expenditures incurred for defensive medical reasons in 1982 was estimated to be $1.0 billion, 12% of all medical care expenditures. Estimates for the nation were $37 billion, 14% of expenditures. Nationally, 180,000 cesarean deliveries were thought to be performed for defensive motives. In their own institutions, respondents judged 43% of all skull x-rays following injury to be medically justified, 30% to be defensive medicine, 16% to be placebos, and 11% to be physician misjudgments. In considering the economic and noneconomic costs of medical malpractice procedures, the dollar costs of insurance were considered most serious, followed closely by defensive medicine, unfairness, and poorer relations with patients. Thirty-two percent of the responsibility for the negative aspects of malpractice processes was assigned to lawyers, 21% to physicians, 18% to legislatures and courts, 16% to patients, and 13% to insurance companies.

Entities:  

Mesh:

Year:  1984        PMID: 10267273     DOI: 10.1016/0149-7189(84)90029-6

Source DB:  PubMed          Journal:  Eval Program Plann        ISSN: 0149-7189


  3 in total

1.  Defensive practice among psychiatrists: a questionnaire survey.

Authors:  K Passmore; W-C Leung
Journal:  Postgrad Med J       Date:  2002-11       Impact factor: 2.401

2.  Determining the frequency of defensive medicine among general practitioners in Southeast Iran.

Authors:  Mahmood Moosazadeh; Mahtab Movahednia; Nima Movahednia; Mohammadreza Amiresmaili; Iraj Aghaei
Journal:  Int J Health Policy Manag       Date:  2014-03-19

3.  How defensive medicine is defined in European medical literature: a systematic review.

Authors:  Nathalie Baungaard; Pia Ladeby Skovvang; Elisabeth Assing Hvidt; Helle Gerbild; Merethe Kirstine Andersen; Jesper Lykkegaard
Journal:  BMJ Open       Date:  2022-01-20       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.